Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.126EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.126EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.126ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.126ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.47EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.47ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.47ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.47EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.47EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.13.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.13.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.13.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.13.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.13.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.10.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.10.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.10.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.10.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.10.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.10.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.10.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GS.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GS.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GS.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used